angiotensin ii has been researched along with Post-operative Vasoplegic Syndrome in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 13 (72.22) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, A; Blough, B; Guerrero-Miranda, C; Hall, S; Hebert, C; Mathew, C; Monday, KA; Sam, T; Sherwood, M; Sovic, W; Zafar, H | 1 |
| Barker, N; Busse, LW; Petersen, C | 1 |
| Bredeck, JF; Cutler, NS; Khanna, AK; Lata, AL; Rasmussen, BM | 1 |
| Chatterjee, S; Evans, AS; Friedman, B; Greenfeld, CR; Khanna, AK; Klijian, A; Kroll, S; Ortoleva, J; Panwar, R; Reddy, VS | 1 |
| Fifer, S; Michaud, CJ; Trethowan, B | 1 |
| Chow, JH; Mazzeffi, MA; Strauss, E | 1 |
| Danser, AHJ; Palmen, M; Papazisi, O | 1 |
| Edwin, SB | 1 |
| Chow, JH; Khanna, AK; Wieruszewski, PM; Wittwer, ED | 1 |
| Chatterjee, S | 1 |
| Alam, A; Burkhoff, D; Enter, DH; Jermyn, R | 1 |
| Augoustides, JG | 1 |
| Alam, A; Colbert, GB; Gill, J; Hughes, GJ; Mooney, JL; Ragula, N; Salem, M; Sovic, W | 1 |
| Augoustides, JGT; Evans, A; Gutsche, J; Ivascu, NS; Klick, J; Mittel, A; Shaefi, S | 1 |
| Chancer, Z; Chow, JH; Galvagno, SM; Henderson, R; Mazzeffi, MA; McCurdy, MT; Tanaka, KA | 1 |
| Chow, JH; Evans, A; McCurdy, MT; Weiner, M; Zaku, B | 1 |
| Daly, RC; Kashani, KB; Radosevich, MA; Wieruszewski, PM; Wittwer, ED | 1 |
| Daly, RC; Sims, CR; Taner, T; Wieruszewski, PM; Wittwer, ED | 1 |
4 review(s) available for angiotensin ii and Post-operative Vasoplegic Syndrome
| Article | Year |
|---|---|
Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
Topics: Adrenal Cortex Hormones; Angiotensin II; Ascorbic Acid; Cardiac Surgical Procedures; Dopamine; Enzyme Inhibitors; Epinephrine; Humans; Methylene Blue; Norepinephrine; Phenylephrine; Sympathomimetics; Vascular Resistance; Vasoconstrictor Agents; Vasoplegia; Vasopressins | 2020 |
The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
Topics: Angiotensin II; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Randomized Controlled Trials as Topic; United States; Vasoconstrictor Agents; Vasoplegia | 2022 |
Angiotensin II: A Review of Current Literature.
Topics: Angiotensin II; Humans; Shock; United States; Vasoplegia | 2022 |
Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
Topics: Angiotensin II; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Methylene Blue; Risk Factors; Vascular Surgical Procedures; Vasoplegia | 2018 |
1 trial(s) available for angiotensin ii and Post-operative Vasoplegic Syndrome
| Article | Year |
|---|---|
Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
Topics: Angiotensin II; Blood Pressure; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Vasoconstrictor Agents; Vasoplegia | 2021 |
13 other study(ies) available for angiotensin ii and Post-operative Vasoplegic Syndrome
| Article | Year |
|---|---|
Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting.
Topics: Angiotensin II; Heart Transplantation; Heart-Assist Devices; Humans; Retrospective Studies; Vasoplegia | 2021 |
Angiotensin II for Critically Ill Patients With Shock After Heart Transplant.
Topics: Angiotensin II; Critical Illness; Heart Transplantation; Humans; Prospective Studies; Shock; Vasoplegia | 2021 |
Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.
Topics: Angiotensin II; Blood Pressure; Humans; Male; Middle Aged; Pneumonectomy; Renin; Vasoconstrictor Agents; Vasoplegia | 2020 |
Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?
Topics: Angiotensin II; Blood Pressure; Cardiac Surgical Procedures; Humans; Vasoconstrictor Agents; Vasoplegia | 2021 |
How Can We Define a Place in Therapy for Angiotensin II After Cardiac Surgery?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Surgical Procedures; Humans; Vasoplegia | 2021 |
Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
Topics: Angiotensin II; Cardiopulmonary Bypass; Clinical Trials as Topic; Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Postoperative Complications; Vasoconstrictor Agents; Vasoplegia | 2022 |
Commentary: Is angiotensin II a game changer for vasoplegia after cardiac surgery, or is the jury still out?
Topics: Angiotensin II; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Vasoplegia | 2022 |
Underutilized Fuel: Angiotensin II for Vasoplegia in the Heart Failure Patient Population.
Topics: Angiotensin II; Heart Failure; Humans; Vasoplegia | 2021 |
Commentary: Angiotensin II: Expanding the rescue options for vasoplegia.
Topics: Angiotensin II; Cardiopulmonary Bypass; Humans; Methylene Blue; Vasoplegia | 2022 |
When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report.
Topics: Aged; Angiotensin II; Escherichia coli; Escherichia coli Infections; Humans; Intestinal Perforation; Male; Shock, Septic; Streptococcal Infections; Streptococcus anginosus; Treatment Outcome; Vasoplegia | 2018 |
Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
Topics: Aged, 80 and over; Angiotensin II; Cardiopulmonary Bypass; Humans; Male; Methylene Blue; Vasoplegia | 2019 |
Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
Topics: Adult; Angiotensin II; Cardiopulmonary Bypass; Hemodynamics; Humans; Male; Middle Aged; Postoperative Complications; Vasoconstrictor Agents; Vasoplegia | 2019 |
Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology.
Topics: Adult; Angiotensin II; Female; Heart Defects, Congenital; Heart Transplantation; Humans; Liver Transplantation; Shock, Surgical; Systole; Vasoconstrictor Agents; Vasoplegia | 2019 |